Non-Alzheimer's Disease Dementias: Anatomic,Clinical,and Molecular Correlates

Baker M Litvan I Houlden H Adamson J Dickson D Perez-Tur J , and others. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711–5.

Lynch T Sano M Marder KS Bell KL Foster NL Defendini RF , and others. Clinical characteristics of a family with chromosome 17-linked disinhibition–dementia–parkinsonism–amyotrophy complex. Neurology 1994;44:1878–84.

Wilhelmsen KC Lynch T Pavlou E Higgins M Nygaard TG . Localization of disinhibition–dementia–parkinsonism–amyotrophy complex to 17q21–22. Am J Hum Genet 1994;55:1159–65.

Hutton M Lendon CL Rizzu P Baker M Froelich S Houlden H , and others. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–5.

Feany MB Dickson DW . Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388–96.

Conrad C Andreadis A Trojanowski JQ Dickson DW Kang D Chen X , and others. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997;41:277–81.

Houlden H Baker M Morris HR MacDonald N Pickering-Brown S Adamson J , and others. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001;56:1702–6.

Neary D Snowden JS Gustafson L Passant U Stuss D Black S , and others. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54.

Ratnavalli E Brayne C Dawson K Hodges JR . The prevalence of frontotemporal dementia. Neurology 2002;58:1615–21.

Morita K Kaiya H Ikeda T Namba M. Presenile dementia combined with amyotrophy: A review of 34 Japanese cases. Arch Gerontol Geriatr 1987;6:263–77.

Neary D Snowden JS Mann DM Northen B Goulding PJ Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990;53:23–32.

Lomen-Hoerth C Anderson T Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077–9.

Hosler BA Siddique T Sapp PC Sailor W Huang MC Hossain A , and others. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000;284:1664–9.

Caselli RJ Windebank AJ Petersen RC Komori T Parisi JE Okazaki H , and others. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993;33:200–7.

Mesulam MM . Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592–8.

Snowden JS Bathgate D Varma A Blackshaw A Gibbons ZC Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 2001;70:323–32.

Rosen HJ Perry RJ Murphy J Kramer JH Mychack P Schuff N , and others. Emotion comprehension in the temporal variant of frontotemporal dementia. Brain 2002;125:2286–95.

Edwards-Lee T Miller BL Benson DF Cummings JL Russell GL Boone K , and others. The temporal variant of frontotemporal dementia. Brain 1997;120:1027–40.

Mychack P Kramer JH Boone KB Miller BL . The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia. Neurology 2001;56:S11–S15.

McKhann GM Albert MS Grossman M Miller B Dickson D Trojanowski JQ . Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803–9.

Galton CJ Patterson K Xuereb JH Hodges JR . Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484–98.

Kertesz A Munoz DG . Primary progressive aphasia and Pick complex. J Neurol Sci 2003;206:97–107.

Rebeiz JJ Kolodny EH Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20–33.

Gibb WR Luthert PJ Marsden CD . Corticobasal degeneration. Brain 1989;112:1171–92.

Pillon B Blin J Vidailhet M Deweer B Sirigu A Dubois B , and others. The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477–83.

Grimes DA Lang AE Bergeron CB . Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;53:1969–74.

Frattali CM Grafman J Patronas N Makhlouf F Litvan I. Language disturbances in corticobasal degeneration. Neurology 2000;54:990–2.

Kertesz A Martinez-Lage P Davidson W Munoz DG . The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368–75.

Boeve BF Maraganore DM Parisi JE Ahlskog JE Graff-Radford N Caselli RJ , and others. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795–800.

Horoupian DS Wasserstein PH . Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol (Berl) 1999;98:317–22.

Dickson DW Bergeron C Chin SS Duyckaerts C Horoupian D Ikeda K , and others. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935–46.

Boeve BF Lang AE Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54:S15–S19.

Litvan I Agid Y Calne D Campbell G Dubois B Duvoisin RC , and others. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47:1–9.

Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 1999;9:663–79.

Mailliot C Sergeant N Bussiere T Caillet-Boudin ML Delacourte A Buee L. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 1998;433:201–4.

Liu WK Le TV Adamson J Baker M Cookson N Hardy J , and others. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 2001;50:494–502.

Di Maria E Tabaton M Vigo T Abbruzzese G Bellone E Donati C , and others. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000;47:374–7.

Jensen PH Gai WP . Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration. Adv Exp Med Biol 2001;487:129–34.

Davidson WS Jonas A Clayton DF George JM . Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 1998;273:9443–9.

Li JY Jensen P Henning Dahlstrom A. Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 2002;113:463–78.

Tamo W Imaizumi T Tanji K Yoshida H Mori F Yoshimoto M , and others. Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels. Neurosci Lett 2002;326:5–8.

Abeliovich A Schmitz Y Farinas I Choi-Lundberg D Ho W-H Castillo PE , and others. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000;25:239–52.

Cabin DE Shimazu K Murphy D Cole NB Gottschalk W McIlwain KL , and others. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 2002;22:8797–807.

Polymeropoulos MH Lavedan C Leroy E Ide SE Dehejia A Dutra A , and others. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045–7.

Wakabayashi K Hayashi S Kakita A Yamada M Toyoshima Y Yoshimoto M , and others. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 1998;96:445–52.

Giasson BI Uryu K Trojanowski JQ Lee VM . Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 1999;274:7619–22.

McKeith IG Galasko D Kosaka K Perry EK Dickson DW Hansen LA , and others. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113–24.

Ballard C O'Brien J Gray A Cormack F Ayre G Rowan E , and others. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2001;58:977–82.

Simard M van Reekum R Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2000;12:425–50.

Klatka LA Louis ED Schiffer RB . Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996;47:1148–52.

Marantz AG Verghese J. Capgras' syndrome in dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2002;15:239–41.

Ballard C Piggott M Johnson M Cairns N Perry R McKeith I , and others. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 2000;48:868–76.

Boeve BF Silber MH Parisi JE Dickson DW Ferman TJ Benarroch EE , and others. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40–5.

Del Ser T McKeith I Anand R Cicin-Sain A Ferrara R Spiegel R. Dementia with lewy bodies: Findings from an international multicentre study. Int J Geriatr Psychiatry 2000;15:1034–45.

Ballard CG Court JA Piggott M Johnson M O'Brien J McKeith I , and others. Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Conscious Cogn 2002;11:461–74.

Burton EJ Karas G Paling SM Barber R Williams ED Ballard CG , and others. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 2002;17:618–30.

Piggott MA Marshall EF Thomas N Lloyd S Court JA Jaros E , and others. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution. Brain 1999;122:1449–68.

Leverenz JB Miller MA Dobie DJ Peskind ER Raskind MA . Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies. Neurobiol Aging 2001;22:555–61.

Graham JG Oppenheimer DR . Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28–34.

Ghorayeb I Yekhlef F Chrysostome V Balestre E Bioulac B Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72:798–800.

Goto K Ueki A Shimode H Shinjo H Miwa C Morita Y. Depression in multiple system atrophy: A case report. Psychiatry Clin Neurosci 2000;54:507–11.

Fetoni V Soliveri P Monza D Testa D Girotti F. Affective symptoms in multiple system atrophy and Parkinson's disease: Response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999;66:541–44.

Berent S Giordani B Gilman S Trask CL Little RJ Johanns JR , and others. Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn 2002;50:194–206.

Robbins TW James M Lange KW Owen AM Quinn NP Marsden CD . Cognitive performance in multiple system atrophy. Brain 1992;115:271–91.

Robbins TW James M Owen AM Lange KW Lees AJ Leigh PN , and others. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994;57:79–88.

Dickson DW Liu W Hardy J Farrer M Mehta N Uitti R , and others. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 1999;155:1241–51.

Swartz JR Miller BL Lesser IM Darby AL . Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997;58:212–6.

Moretti R Torre P Antonello RM Cazzato G Bava A. Frontotemporal dementia: Paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol 2003;49:13–19.

Moretti R Torre P Antonello RM Cazzato G Bava A. Effects of selegiline on fronto-temporal dementia: A neuropsychological evaluation. Int J Geriatr Psychiatry 2002;17:391–2.

Adler G Teufel M Drach LM . Pharmacological treatment of frontotemporal dementia: Treatment response to the MAO-A inhibitor moclobemide. Int J Geriatr Psychiatry 2003;18:653–5.

Cummings JL Mega M Gray K Thompson-Rosenberg J Carusi DA Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–14.

Stroop J. Studies of interferences in serial verbal reactions. J Exp Psychology 1935;18:643–62.

Shea C MacKnight C Rockwood K. Donepezil for treatment of dementia with Lewy bodies: A case series of nine patients. Int Psychogeriatr 1998;10:229–38.

Samuel W Caligiuri M Galasko D Lacro J Marini M McClure FS , and others. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. Int J Geriatr Psychiatry 2000;15:794–802.

McKeith IG Grace JB Walker Z Byrne EJ Wilkinson D Stevens T , and others. Rivastigmine in the treatment of dementia with Lewy bodies: Preliminary findings from an open trial. Int J Geriatr Psychiatry 2000;15:387–92.

McKeith I Del Ser T Spano P Emre M Wesnes K Anand R , and others. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031–6.